Overview
Leptospirosis is an infectious disease caused by pathogenic spirochete bacteria of the genus Leptospira. It is a zoonotic illness, meaning it is transmitted from animals to humans, typically through contact with water, soil, or food contaminated with the urine of infected animals such as rodents, dogs, cattle, and pigs. The bacteria can enter the body through cuts or abrasions in the skin, through mucous membranes (eyes, nose, mouth), or through ingestion of contaminated water. Leptospirosis is also known as Weil disease (in its severe form), canicola fever, swamp fever, mud fever, or hemorrhagic jaundice. The disease affects multiple body systems and has a wide clinical spectrum ranging from mild, self-limiting febrile illness to severe, life-threatening multiorgan dysfunction. Common symptoms include high fever, severe headache, muscle pain (particularly in the calves and lower back), chills, conjunctival suffusion (redness of the eyes without discharge), nausea, vomiting, diarrhea, and skin rash. The illness typically presents in two phases: an initial acute septicemic phase lasting about a week, followed by an immune phase. In severe cases (Weil disease, corresponding to ICD-10 code A27.0), patients may develop jaundice, renal failure, hemorrhagic manifestations, pulmonary hemorrhage, meningitis, and cardiovascular collapse, which can be fatal if untreated. Treatment involves antibiotic therapy, with doxycycline and penicillin being the most commonly used agents for mild and severe cases, respectively. Intravenous penicillin G or ceftriaxone is recommended for severe leptospirosis. Supportive care, including fluid management, dialysis for renal failure, and mechanical ventilation for pulmonary complications, may be necessary in severe cases. Early diagnosis and prompt antibiotic treatment significantly improve outcomes. Doxycycline may also be used as prophylaxis in high-risk exposure settings. Leptospirosis is most prevalent in tropical and subtropical regions, particularly during rainy seasons and flooding events, and is considered one of the most widespread zoonotic diseases globally.
Clinical phenotype terms— hover any for plain English:
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
7 eventsInstitut Pasteur — NA
University Hospital Center of Martinique — PHASE4
National Kidney and Transplant Institute, Philippines — PHASE2
Centre Hospitalier Universitaire de la Réunion — NA
Institut National de la Santé Et de la Recherche Médicale, France — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Leptospirosis.
5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Leptospirosis.
Community
No community posts yet. Be the first to share your experience with Leptospirosis.
Start the conversation →Latest news about Leptospirosis
Disease timeline:
New recruiting trial: Chronic Post-leptospirosis Manifestations in Reunion
A new clinical trial is recruiting patients for Leptospirosis
New recruiting trial: Preventive Strategies for Early and Late Complications of Leptospirosis
A new clinical trial is recruiting patients for Leptospirosis
New recruiting trial: Leptospirosis Care Bundle Study
A new clinical trial is recruiting patients for Leptospirosis
New recruiting trial: Leptospirosis Registry - LeptoScope
A new clinical trial is recruiting patients for Leptospirosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Leptospirosis
What is Leptospirosis?
Leptospirosis is an infectious disease caused by pathogenic spirochete bacteria of the genus Leptospira. It is a zoonotic illness, meaning it is transmitted from animals to humans, typically through contact with water, soil, or food contaminated with the urine of infected animals such as rodents, dogs, cattle, and pigs. The bacteria can enter the body through cuts or abrasions in the skin, through mucous membranes (eyes, nose, mouth), or through ingestion of contaminated water. Leptospirosis is also known as Weil disease (in its severe form), canicola fever, swamp fever, mud fever, or hemorrha
Are there clinical trials for Leptospirosis?
Yes — 5 recruiting clinical trials are currently listed for Leptospirosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Leptospirosis?
25 specialists and care centers treating Leptospirosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.